Cycloheptyl CP 55,940

Cycloheptyl CP 55,940
Identifiers
	IUPAC name (1R,3R,4R)-3-[4-(1,1-dimethylheptyl)-2-hydroxyphenyl]-4-(3-hydroxypropyl)cycloheptan-1-ol;
Chemical and physical data
Formula	C25H42O3
Molar mass	390.608 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O[C@H]1C[C@H]([C@H](CCCO)CCC1)c1ccc(cc1O)C(C)(C)CCCCCC;

Cycloheptyl CP 55,940 is a synthetic cannabinoid related to CP 55,940 but is a ring-expanded homologue with a cycloheptyl ring in place of the cyclohexyl ring. It was first synthesized by Pfizer in the 1980s. It falls outside the definition of a "cyclohexylphenol derivative" since it does not have a cyclohexyl ring. Cycloheptyl CP 55,940 has similar potency to CP 55,940 itself, with an ED₅₀ of 0.06 mg/kg in animal studies.^[1]

References

^ US 4371720, Johnson MR, Melvin LS, "2-Hydroxy-4-(substituted) phenyl cycloalkanes and derivatives.", issued 1 February 1983, assigned to Pfizer Inc.

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

[1] US 4371720, Johnson MR, Melvin LS, "2-Hydroxy-4-(substituted) phenyl cycloalkanes and derivatives.", issued 1 February 1983, assigned to Pfizer Inc.

[1]

See also

References